Five updates:
1. Thirty-nine people have died from EVALI — e-cigarette, or vaping, product use associated lung injury — in 24 states, up from 37 deaths a week prior. The deceased patients range in age from 17 to 75.
2. Of 1,364 patients with available age data, the majority (79 percent) are under age 35.
3. Of this group, 14 percent of patients are under age 18, 40 percent are ages 18-24, 25 percent are ages 25-34 and 21 percent are 35 or older.
4. EVALI-related Hospital admissions peaked the week of Sept. 8 at 201 admissions, declining steadily since then. Thirteen hospital admissions were reported the week of Oct. 23, which represents the most recent data available.
5. The source of the illness is still unknown. The only commonality among all cases is that patients use e-cigarettes or vaping products.
More articles on clinical leadership & infection control:
Joint Commission to roll out new maternal care standards in 2020
Washington hospital cited for 22 care deficiencies after state audit
1 in 5 older adults take leftover antibiotics, survey finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.